A large, US based, observational, real-world database, to identify clinical, demographic, and physician-related factors associated with women's adherence to Premarin® Vaginal Cream.

Trial Profile

A large, US based, observational, real-world database, to identify clinical, demographic, and physician-related factors associated with women's adherence to Premarin® Vaginal Cream.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2017

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Atrophic vaginitis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 27 Nov 2017 New trial record
    • 14 Oct 2017 Results presented at the North American Menopause Society 2017 Annual Meeting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top